Financing type:  underwritten prospectus offering

Gross proceeds:  $91,999,800

Offering:  10,222,200 common listed shares

Offering price:  $9 per listed share

Warrant exercise terms:  nil

Overallotment option:  The underwriters may purchase a maximum of 1,333,300 common listed shares for overallotment purposes. As of Sept. 11, 2025, such option has expired and 1,333,300 common listed shares have been issued thereunder. All information presented herein includes such exercise.

Commissions in securities:  nil

Disclosure:  Refer to the prospectus dated Aug. 28, 2025, and the company's news releases dated Aug. 14, 2025, Aug. 29, 2025, and Sept. 4, 2025.